Kritische 8-K Meldungen
| Datum | Meldung | Schwere | Filing | Auszug |
|---|---|---|---|---|
| 11.12.2025 | Item 5.02 — Abgang Schlüsselpersonen | HOCH | SEC | (a) of the Exchange Act. ☒ Item 5.02. Departure of Directors or Certain Officers; Election of Directors; Appointment |
| 07.10.2025 | Item 5.02 — Abgang Schlüsselpersonen | HOCH | SEC | (a) of the Exchange Act. ☒ Item 5.02. Departure of Directors or Certain Officers; Election of Directors; Appointment |
| 21.08.2025 | Item 5.02 — Abgang Schlüsselpersonen | HOCH | SEC | other things, the management changes described in Item 5.02 of this Current Report on Form 8-K. A copy of this press rel |
| 12.05.2025 | Item 5.02 — Abgang Schlüsselpersonen | HOCH | SEC | (a) of the Exchange Act. ☒ Item 5.02. Departure of Directors or Certain Officers; Election of Directors; Appointment |
| 25.07.2024 | Item 5.02 — Abgang Schlüsselpersonen | HOCH | SEC | (a) of the Exchange Act. ☒ Item 5.02. Departure of Directors or Certain Officers; Election of Directors; Appointment |
Stammdaten
Scilex Holding Company, a biopharmaceutical company, focuses on developing and commercializing non-opioid management products for the treatment of acute and chronic pain. Its commercial product is ZTlido 1.8%, a prescription lidocaine topical product for the relief of neuropathic pain related with post-herpetic neuralgia, which is a form of post-shingles nerve pain. It also offers SP-102, a viscous gel formulation of corticosteroid for epidural injections that is in a Phase III clinical trial to treat lumbosacral radicular pain; SP-103, which is in Phase II clinical trail for the treatment of low back pain; and SP-104, a novel low-dose delayed-release naltrexone hydrochloride formulation that has completed Phase I clinical trial for the treatment of fibromyalgia. The company is headquartered in Palo Alto, California. Scilex Holding Company is a subsidiary of Sorrento Therapeutics, Inc.
Unternehmen & Branche
| Name | Scilex Holding Co |
|---|---|
| Ticker | SCLX |
| CIK | 0001820190 |
| Boerse | US |
| Sektor | Healthcare |
| Industrie | Drug Manufacturers - General |
| SIC | 2836 · Biological Products, (No Diagnostic Substances) |
Wertpapier & Kennzahlen
| CUSIP | 80880W106 |
|---|---|
| ISIN | US80880W1062 |
| Typ | Common Stock |
| Marktkapitalisierung | 72,8 Mio. USD |
| Beta | 1,42 |
| Dividendenrendite | 0,00 % |
Externe Quellen: SEC EDGAR » · FMP-Profil » · Yahoo Finance »
Finanzkennzahlen (SEC XBRL)
| Periode | Filing | Umsatz | Nettoergebnis | EPS | Aktiva | Eigenkapital |
|---|---|---|---|---|---|---|
| 2025-12-31 | 10-K | 30,253,000 | -374,053,000 | -36.48 | 364,981,000 | -207,781,000 |
| 2025-09-30 | 10-Q | 10,560,000 | -257,820,000 | -22.17 | 275,879,000 | -176,936,000 |
| 2025-06-30 | 10-Q | 9,896,000 | -44,048,000 | -7.42 | 83,755,000 | -248,987,000 |
| 2025-03-31 | 10-Q | 5,004,000 | -26,080,000 | -2.26 | 78,976,000 | -211,484,000 |
| 2024-12-31 | 10-K | 56,590,000 | -72,807,000 | -8.05 | 92,953,000 | -192,641,000 |
| 2024-09-30 | 10-Q | 14,436,000 | -4,388,000 | -0.58 | 100,430,000 | -211,317,000 |
| 2024-06-30 | 10-Q | 16,370,000 | -37,582,000 | -7.67 | 104,544,000 | -214,692,000 |
| 2024-03-31 | 10-Q | 10,884,000 | -24,377,000 | -8.33 | 91,240,000 | -189,786,000 |
| 2023-12-31 | 10-K | 46,743,000 | -114,331,000 | -1.28 | 101,309,000 | -172,938,000 |
| 2023-09-30 | 10-Q | 10,117,000 | -35,529,000 | -0.63 | 80,528,000 | -162,669,000 |
| 2023-06-30 | 10-Q | 12,582,000 | -26,649,000 | -0.19 | 126,464,000 | 10,417,000 |
| 2023-03-31 | 10-Q | 10,582,000 | -30,753,000 | -0.22 | 86,051,000 | 11,076,000 |
| 2022-12-31 | 10-K | 38,034,000 | -23,364,000 | -0.17 | 86,527,000 | 36,239,000 |
| 2022-09-30 | 10-Q | 11,377,000 | 21,501,000 | 0.16 | 101,458,835 | -12,003,010 |
| 2022-06-30 | 10-Q | 7,926,000 | -17,838,000 | -0.13 | 142,299,446 | -10,764,731 |
| 2022-03-31 | 10-Q | 6,812,000 | -9,143,000 | -0.07 | 140,972,035 | -10,538,321 |
| 2021-12-31 | 10-K | 31,317,000 | -88,424,000 | -0.67 | 77,932,000 | -223,876,000 |
| 2021-09-30 | 10-Q | -1,444,352 | -0.08 | 139,640,184 | -9,829,785 | |
| 2021-06-30 | 10-Q | -233,749 | -0.01 | 139,898,192 | -8,385,433 | |
| 2021-03-31 | 10-Q | 1,328,853 | 0.09 | 140,060,726 | -8,151,684 |
Fondsaktivität (Vorquartalsvergleich)
| Fonds | Aktuell (Stk) | Vorquartal (Stk) | Veränderung (Stk) | Wert (USD) | Status | Δ | Trend |
|---|---|---|---|---|---|---|---|
| VANGUARD GROUP INC | 295,024 | 0 | 295,024 | 3,599,293 | Neu | +100,0% | |
| BlackRock, Inc. | 98,333 | 0 | 98,333 | 1,199,663 | Neu | +100,0% | |
| RENAISSANCE TECHNOLOGIES LLC | 38,464 | 0 | 38,464 | 469,261 | Neu | +100,0% | |
| STATE STREET CORP | 34,354 | 0 | 34,354 | 419,119 | Neu | +100,0% | |
| 683 Capital Management, LLC | 27,312 | 0 | 27,312 | 333,206 | Neu | +100,0% | |
| XTX Topco Ltd | 20,444 | 0 | 20,444 | 249,417 | Neu | +100,0% | |
| CITIGROUP INC | 19,846 | 0 | 19,846 | 242,121 | Neu | +100,0% | |
| NORTHERN TRUST CORP | 15,033 | 0 | 15,033 | 183,402 | Neu | +100,0% | |
| MORGAN STANLEY | 14,606 | 0 | 14,606 | 178,195 | Neu | +100,0% | |
| UBS Group AG | 11,971 | 0 | 11,971 | 144,037 | Neu | +100,0% | |
| Qube Research & Technologies Ltd | 11,575 | 0 | 11,575 | 141,215 | Neu | +100,0% | |
| BANK OF AMERICA CORP /DE/ | 7,675 | 0 | 7,675 | 90,426 | Neu | +100,0% | |
| JPMORGAN CHASE & CO | 3,035 | 0 | 3,035 | 37,027 | Neu | +100,0% | |
| Tower Research Capital LLC (TRC) | 2,883 | 0 | 2,883 | 35,173 | Neu | +100,0% | |
| CREATIVE FINANCIAL DESIGNS INC /ADV | 1,853 | 0 | 1,853 | 22,607 | Neu | +100,0% | |
| OSAIC HOLDINGS, INC. | 1,148 | 0 | 1,148 | 13,993 | Neu | +100,0% | |
| JONES FINANCIAL COMPANIES LLLP | 1,116 | 0 | 1,116 | 13,615 | Neu | +100,0% | |
| MetLife Investment Management, LLC | 1,090 | 0 | 1,090 | 13,298 | Neu | +100,0% | |
| ROYAL BANK OF CANADA | 884 | 0 | 884 | 11,000 | Neu | +100,0% | |
| DEUTSCHE BANK AG\ | 800 | 0 | 800 | 9,760 | Neu | +100,0% | |
| Versant Capital Management, Inc | 761 | 0 | 761 | 9,284 | Neu | +100,0% | |
| MCF Advisors LLC | 474 | 0 | 474 | 5,783 | Neu | +100,0% | |
| LANDSCAPE CAPITAL MANAGEMENT, L.L.C. | 43,824 | 0 | 43,824 | 4,159 | Neu | +100,0% | |
| Activest Wealth Management | 302 | 0 | 302 | 3,684 | Neu | +100,0% | |
| KLP KAPITALFORVALTNING AS | 290 | 0 | 290 | 3,538 | Neu | +100,0% | |
| GAMMA Investing LLC | 126 | 0 | 126 | 1,537 | Neu | +100,0% | |
| WELLS FARGO & COMPANY/MN | 121 | 0 | 121 | 1,476 | Neu | +100,0% | |
| Fortitude Family Office, LLC | 80 | 0 | 80 | 976 | Neu | +100,0% | |
| RHUMBLINE ADVISERS | 35 | 0 | 35 | 427 | Neu | +100,0% | |
| NORTHWESTERN MUTUAL WEALTH MANAGEMENT CO | 29 | 0 | 29 | 354 | Neu | +100,0% | |
| Newbridge Financial Services Group, Inc. | 24 | 0 | 24 | 293 | Neu | +100,0% | |
| New England Capital Financial Advisors LLC | 23 | 0 | 23 | 281 | Neu | +100,0% | |
| Clear Street Group Inc. | 2,880 | 0 | 2,880 | 273 | Neu | +100,0% | |
| DANSKE BANK A/S | 20 | 0 | 20 | 244 | Neu | +100,0% | |
| Operose Advisors LLC | 20 | 0 | 20 | 244 | Neu | +100,0% | |
| BNP PARIBAS FINANCIAL MARKETS | 18 | 0 | 18 | 220 | Neu | +100,0% | |
| MAI Capital Management | 16 | 0 | 16 | 196 | Neu | +100,0% | |
| Pacifica Partners Inc. | 14 | 0 | 14 | 183 | Neu | +100,0% | |
| CoreCap Advisors, LLC | 12 | 0 | 12 | 146 | Neu | +100,0% | |
| Rockefeller Capital Management L.P. | 11 | 0 | 11 | 134 | Neu | +100,0% | |
| State of Wyoming | 9 | 0 | 9 | 116 | Neu | +100,0% | |
| SBI Securities Co., Ltd. | 9 | 0 | 9 | 110 | Neu | +100,0% | |
| Steward Partners Investment Advisory, LLC | 9 | 0 | 9 | 110 | Neu | +100,0% | |
| FMR LLC | 7 | 0 | 7 | 85 | Neu | +100,0% | |
| US BANCORP \DE\ | 7 | 0 | 7 | 85 | Neu | +100,0% | |
| Legacy Wealth Managment, LLC/ID | 6 | 0 | 6 | 74 | Neu | +100,0% | |
| Allworth Financial LP | 6 | 0 | 6 | 74 | Neu | +100,0% | |
| ARMSTRONG ADVISORY GROUP, INC | 5 | 0 | 5 | 61 | Neu | +100,0% | |
| Measured Wealth Private Client Group, LLC | 4 | 0 | 4 | 49 | Neu | +100,0% | |
| CIBC Private Wealth Group LLC | 4 | 0 | 4 | 49 | Neu | +100,0% |
Insider-Transaktionen (12 Monate)
Keine Insider-Käufe/Verkäufe in den letzten 12 Monaten.
Top-Fondshalter
Hinweis: Keine aktuelleren Daten zu dieser Aktie verfuegbar. Stand der gezeigten 13F-Holdings: 31.12.2025. Letztes global veroeffentlichtes 13F-Quartal: 31.03.2026.
| Fonds | Anteile | Wert (USD) | Anteil (%) |
|---|---|---|---|
| VANGUARD GROUP INC | 295,024 | 3,599,293 | 48.37 |
| BlackRock, Inc. | 98,333 | 1,199,663 | 16.12 |
| RENAISSANCE TECHNOLOGIES LLC | 38,464 | 469,261 | 6.31 |
| STATE STREET CORP | 34,354 | 419,119 | 5.63 |
| 683 Capital Management, LLC | 27,312 | 333,206 | 4.48 |
| XTX Topco Ltd | 20,444 | 249,417 | 3.35 |
| CITIGROUP INC | 19,846 | 242,121 | 3.25 |
| NORTHERN TRUST CORP | 15,033 | 183,402 | 2.46 |
| MORGAN STANLEY | 14,606 | 178,195 | 2.39 |
| UBS Group AG | 11,971 | 144,037 | 1.94 |
| Qube Research & Technologies Ltd | 11,575 | 141,215 | 1.90 |
| BANK OF AMERICA CORP /DE/ | 7,675 | 90,426 | 1.22 |
| JPMORGAN CHASE & CO | 3,035 | 37,027 | 0.50 |
| Tower Research Capital LLC (TRC) | 2,883 | 35,173 | 0.47 |
| CREATIVE FINANCIAL DESIGNS INC /ADV | 1,853 | 22,607 | 0.30 |
| OSAIC HOLDINGS, INC. | 1,148 | 13,993 | 0.19 |
| JONES FINANCIAL COMPANIES LLLP | 1,116 | 13,615 | 0.18 |
| MetLife Investment Management, LLC | 1,090 | 13,298 | 0.18 |
| ROYAL BANK OF CANADA | 884 | 11,000 | 0.15 |
| DEUTSCHE BANK AG\ | 800 | 9,760 | 0.13 |